{"id":54439,"date":"2023-03-02T16:07:21","date_gmt":"2023-03-02T15:07:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/"},"modified":"2023-03-02T16:07:21","modified_gmt":"2023-03-02T15:07:21","slug":"particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/","title":{"rendered":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment"},"content":{"rendered":"
\n

\nThe Certification Reinforces Company\u2019s Commitment to Maintaining the Highest Level of Security in Healthcare and Technology.<\/i>\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–Particle Health,<\/a> a developer-friendly API platform for bi-directional healthcare data exchange, announced that it has achieved the HITRUST Implemented i1 Validated Assessment<\/a>. The accreditation leverages a proven set of curated controls to ensure that Particle is exercising HITRUST i1 Leading Security Practices to implement a strong and broad cybersecurity program. The certification represents another step forward in Particle\u2019s efforts to safeguard protected health information (PHI) and exceed the industry\u2019s most stringent security and privacy measures.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAchieving the HITRUST Implemented i1 Validated Assessment showcases Particle Health\u2019s commitment to security and privacy, our top priorities and true differentiators,\u201d said Troy Bannister, CEO of Particle Health. \u201cAbove all, our mission is to better serve patients, of which protecting their health data is paramount. Particle not only meets but exceeds all legislative requirements regarding access to PHI by maintaining the letter and the spirit of these critically important laws.\u201d\n<\/p>\n

\nHITRUST Implemented i1 Leading Security Practices Assessment delivers comprehensive and reliable assurances against current and emerging cyber threats. It supports a complete cybersecurity program that evolves based on regular analysis of threat intelligence data and implementation to practically assess information security operational maturity with greater efficiency. The recent certification ensures that Particle\u2019s sensitive data and PHI are effectively and efficiently protected with stringent security and privacy measures.\n<\/p>\n

\nParticle remains committed to adhering to the healthcare industry\u2019s safety and compliance requirements. With a mission to enable simple and secure access to actionable healthcare data, Particle\u2019s systems were built to ensure data security, availability, processing integrity, confidentiality, and privacy at all times. To learn more about the organization\u2019s commitment to these measures, please click here<\/a>.\n<\/p>\n

\nAbout Particle Health<\/b>\n<\/p>\n

\nFounded in 2018, Particle Health has built the integrations and APIs that enable a modern, seamless data experience for healthcare companies. We create intuitive experiences for developers, build scalable infrastructure product teams love, and collaborate with innovative leaders launching data-driven healthcare solutions. Learn more about Particle at: https:\/\/www.particlehealth.com\/<\/a> or access the press kit at https:\/\/go.particlehealth.com\/press-kit<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Jessy Green
\n
SVM PR
\n
jessy.green@svmpr.com<\/a>
1-401-490-9700\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Certification Reinforces Company\u2019s Commitment to Maintaining the Highest Level of Security in Healthcare and Technology. NEW YORK–(BUSINESS WIRE)–Particle Health, a developer-friendly API platform for bi-directional healthcare data exchange, announced that it has achieved the HITRUST Implemented i1 Validated Assessment. The accreditation leverages a proven set of curated controls to ensure that Particle is exercising … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54439","6":"format-standard","7":"category-industry"},"yoast_head":"\nParticle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The Certification Reinforces Company\u2019s Commitment to Maintaining the Highest Level of Security in Healthcare and Technology. NEW YORK–(BUSINESS WIRE)–Particle Health, a developer-friendly API platform for bi-directional healthcare data exchange, announced that it has achieved the HITRUST Implemented i1 Validated Assessment. The accreditation leverages a proven set of curated controls to ensure that Particle is exercising ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-02T15:07:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment\",\"datePublished\":\"2023-03-02T15:07:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005207\\\/en\\\/1727871\\\/21\\\/PARTICLE_01_LOGO_01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/\",\"name\":\"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005207\\\/en\\\/1727871\\\/21\\\/PARTICLE_01_LOGO_01.jpg\",\"datePublished\":\"2023-03-02T15:07:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005207\\\/en\\\/1727871\\\/21\\\/PARTICLE_01_LOGO_01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230302005207\\\/en\\\/1727871\\\/21\\\/PARTICLE_01_LOGO_01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/","og_locale":"en_US","og_type":"article","og_title":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend","og_description":"The Certification Reinforces Company\u2019s Commitment to Maintaining the Highest Level of Security in Healthcare and Technology. NEW YORK–(BUSINESS WIRE)–Particle Health, a developer-friendly API platform for bi-directional healthcare data exchange, announced that it has achieved the HITRUST Implemented i1 Validated Assessment. The accreditation leverages a proven set of curated controls to ensure that Particle is exercising ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-02T15:07:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment","datePublished":"2023-03-02T15:07:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/"},"wordCount":382,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/","url":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/","name":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg","datePublished":"2023-03-02T15:07:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230302005207\/en\/1727871\/21\/PARTICLE_01_LOGO_01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/particle-health-achieves-hitrust-implemented-1-year-i1-validated-assessment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Particle Health Achieves HITRUST Implemented, 1-Year (i1) Validated Assessment"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54439"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54439\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}